In the tumor microenvironment, PD-L1 is expressed on the tumor cell surface and the binding of PD-1 expressed by TILs may lead to the functional inactivation of TILs and loss of their ability to kill tumor cells that result in immune resistance in patients with tumors (23, 24). Here, CD274 is linked to neoplasm.